01—Abstract
Summary
Summary of the 10-Q filed April 24, 2026. Cited figures are marked; the original filing is the authoritative source.
CME Group Inc. reported strong financial results for the first quarter of 2026, with total revenues increasing by 14% year-over-year to $1.88 billiona.
This growth was primarily driven by a significant 15% increase in clearing and transaction fees, fueled by a 22% rise in contract volume. The company benefited from heightened market volatility across various asset classes, including interest rates, energy, and metals, largely attributed to ongoing geopolitical conflicts and resultant economic uncertainty. Despite an increase in operating expenses by 7% to $570.4 millionb, driven by higher compensation, technology, and licensing costs, CME Group maintained a robust operating margin of 69.7%.
Net income saw a substantial 21% increase to $1.15 billionc, resulting in diluted earnings per share of $3.18, also up 21%. The company's liquidity remains strong, with $2.4 billion in cash and cash equivalents (excluding restricted cash) and significant borrowing capacity available. CME Group also continued its share repurchase program, having repurchased approximately $539 million of its Class A common stock during the quarter.
02—Key points
Key Highlights
- Total revenues grew 14% to $1.88 billion in Q1 2026 compared to Q1 2025.
- Clearing and transaction fees increased by 15% to $1.54 billion, driven by a 22% surge in total contract volume.
- Net income rose 21% to $1.15 billion, with diluted EPS increasing to $3.18.
- Market volatility, attributed to geopolitical events, boosted volume across interest rates, energy, and metals.
- Operating expenses increased 7% to $570.4 million, primarily due to higher compensation, technology, and licensing costs.
- The company repurchased approximately $539 million of its Class A common stock during the quarter under its $3.0 billion share repurchase program.
- Strong liquidity position maintained, with $2.4 billion in cash and cash equivalents (excluding restricted cash).
03—One dollar
04—Financials
Financial Highlights
Figures from 10-QQ1 FY2026filed April 24, 2026Financial Statements
Q1 FY2026 against Q1 FY2025
| Line item | Q1 FY2026Q1 FY2025 | Change |
|---|---|---|
| Revenue | $1.88B$1.64B | +14.5% |
| Operating Expenses | $570.40M$534.30M | +6.8% |
| Operating Income | $1.31B$1.11B | +18.2% |
| Net Income | $1.15B$956.20M | +20.7% |
| EPS (Basic) | $3.25$2.63 | +23.6% |
| EPS (Diluted) | $3.18$2.62 | +21.4% |
| Shares Outstanding (Basic) | 359.32M359.61M | −0.1% |
| Shares Outstanding (Diluted) | 363.21M360.23M | +0.8% |
05—Questions
Frequently Asked Questions
What drove the significant increase in CME Group's revenue in the first quarter of 2026?
CME Group's revenue increased by 14% to $1.88 billion primarily due to a 15% rise in clearing and transaction fees. This growth was driven by a substantial 22% increase in total contract volume, which was itself spurred by heightened market volatility across various asset classes like interest rates, energy, and metals, influenced by geopolitical events.
How did operating expenses change, and what were the main drivers?
Operating expenses increased by 7% to $570.4 million. The primary drivers for this increase included higher compensation and benefits costs due to salary increases and headcount growth, increased technology support services for the Google Cloud transformation, and higher licensing fees related to new and high-volume equity products. Employee separation and restructuring costs also contributed to the rise.
What is the company's current financial health and liquidity position?
CME Group demonstrated strong financial health with a 21% increase in net income to $1.15 billion and a healthy operating margin of 69.7%. Liquidity remains robust, with $2.4 billion in cash and cash equivalents (excluding restricted cash) and substantial available borrowing capacity under its credit facilities. The company also actively returned capital to shareholders through its share repurchase program.
What impact is geopolitical conflict having on CME Group's business?
The ongoing geopolitical conflict has been a significant factor contributing to increased market volatility. This volatility has led to higher trading volumes across CME Group's product lines, particularly in interest rates, energy, metals, and some equity index products, as market participants seek to manage risk and capitalize on price movements. This increased volume has directly benefited CME Group's revenue.
06—Continue